Young‐Suk Lim

机构：Ulsan College, Asan Medical Center, University of Ulsan · ORCID：0000-0002-1544-577X

发表论文 587 篇 · 总被引 22151 次 · h-index 76

代表论文

• Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial (2025 · Nature Medicine · 被引 13)
• Non-contrast magnetic resonance imaging for detection of late recurrent hepatocellular carcinoma after curative treatment: a prospective multicenter comparison to contrast-enhanced computed tomography (2025 · Clinical and Molecular Hepatology · 被引 11)
• Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment (2025 · Alimentary Pharmacology & Therapeutics · 被引 9)
• Cost‐Effectiveness of Antiviral Therapy in Patients With High Viremic Indeterminate Phase Chronic Hepatitis B (2025 · Liver International · 被引 2)
• Pain, analgesic use and misconceptions in patients with hepatocellular carcinoma: a cross-sectional survey (2026 · Journal of Liver Cancer · 被引 1)
• High rates of transition to immune active disease in a cohort of strictly defined immune tolerant patients with chronic hepatitis B: results from the RADICAL consortium (2026 · Gut)